Pharma’s Almanac
9/15/23
Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1
OM1 is a real-world data (RWD) and health technology company focused on ingestion, normalization, and linkage of multiple sources of RWD, including structured and unstructured data. The integration of these various sources (EHR, claims, and patient-generated data, for example) provides a more complete view of the patient journey and the safety and effectiveness of healthcare interventions. OM1’s tech-enabled approach for data acquisition and linkage underpins a real-world evidence (RWE) platform that is flexible and reusable to support various use cases and evolving analytic efforts.
In the future, we expect to see integration and curation of increasingly complex data sources with ease as technologies mature. Additionally, the use of artificial intelligence (AI) will accelerate the pace in which data can be processed, variables created from unstructured data, etc. Importantly, we expect that, as more RWD is used in regulatory submissions, there will be clearer guidelines published.